Title: The Retail Pharmacy Landscape: Overcapacity and Survival of the Fittest
The retail pharmacy sector in China is facing a significant challenge, with over 700,000 pharmacies competing for a limited share of the market. The industry’s performance has been severely impacted by an oversupply of pharmacies, leading to declining growth rates, particularly among leading pharmacy chains. In the first half of 2024, six major publicly listed pharmacy companies in China saw a collective decline in profits, signaling a dire need for the industry to restructure.
Industry Dynamics
Overcapacity
- Growth vs. Expansion: Despite a slowdown in overall pharmaceutical sales growth, the number of pharmacies has continued to increase, creating a scenario where more pharmacies than customers (the nun’s soup problem).
- Performance Decline: This overcapacity has led to a decrease in the profitability of major pharmacy chains. For instance, only one company, Yifeng Medicine, reported both revenue and profit growth, with revenue increasing by 9.86% and profits by 13.13%. However, this growth rate has significantly slowed compared to previous years.
Competition and Efficiency
- Store Expansion: Leading pharmacy chains have continued to expand their store networks, with 1000+ new stores added by each of the top companies, with Dachanlin leading with 2077 new stores. This rapid expansion has not been matched by market growth, leading to a decline in operational efficiency.
Challenges and Adjustments
- Market Pressures: Factors such as decreased consumer spending, the cost of opening new stores, and increased operational expenses have collectively led to profit declines for most companies.
- Policy Impact: Changes in policies, such as the implementation of outpatient reimbursement and individual account reforms, have affected consumer behavior and drug purchases, impacting the profitability of pharmacies.
- Strategic Reevaluation: Major pharmacy chains are recalibrating their strategies, focusing on quality and profitability over mere expansion. This includes selective store openings, strategic acquisitions, and an emphasis on digital and professional services.
Outlook
- Decline in Pharmacy Numbers: Industry experts predict a significant decrease in the number of pharmacies, potentially to around 400,000, as a result of market adjustments.
- Shift to Quality and Efficiency: The focus is shifting towards improving the quality of service and efficiency of operations, with a greater emphasis on sales per store and profitability.
Conclusion
The retail pharmacy sector in China is undergoing a period of intense competition and consolidation. The challenges posed by overcapacity and changing market dynamics are prompting major players to restructure their strategies, aiming for quality over quantity, and focusing on operational efficiency and profitability. This transition is expected to reshape the industry, leading to a more sustainable and competitive landscape.
Views: 0